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Abstract 
ICD-11 complex PTSD (CPTSD) is a new condition and therefore there are as yet no clinical 
trials evaluating interventions for its treatment. In this paper, we provide the rationale for a 
flexible multi-modular approach to the treatment of CPTSD, its feasibility and some evidence 
suggesting its potential benefits. The approach highlights flexibility in the selection of 
empirically-supported interventions (or set of interventions) and the order of delivery based 
on symptoms that are impairing, severe and of relevance to the patient. The approach has 
many potential benefits. It can incorporate the use of interventions for which there is already 
evidence of efficacy allowing the leveraging of past scientific efforts. It is also consistent 
with patient-centered care which highlights the importance of patient choice in identification 
of the problems to target, interventions to select and outcomes to monitor. Research on 
modular treatments with other disorders has found that compared to disorder-specific 
manualized protocols, flexible multi-modular treatment programs are superior in resolving 
identified problems and are associated with greater therapist and reduced patient burden. We 
briefly identify types of interventions that have been successful in treating trauma-exposed 
populations along with emerging interventions that are relevant to the particular problems 
associated with exposure to complex trauma and conclude with examples of how such 
treatments can be organized and tested. Research is now urgently needed on the effectiveness 
of existing and new intervention approaches to ICD-11 CPTSD treatment.      
 
Key Words:  Complex PTSD, CPTSD, patient treatment matching, modular sequential 
treatments.   
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In November 2018, The International Society of Traumatic Stress Studies (ISTSS) 
released its third revision of treatment guidelines which included a position paper for 
complex posttraumatic stress disorder (CPTSD) (ISTSS Guidelines Position Paper on 
Complex PTSD in Adults, 2019).  The paper noted past critiques of the CPTSD construct, 
particularly the lack of a consensus concerning its definition and the consequent difficulties 
in providing treatment guidelines. As noted in the position paper, the first of these issues, 
namely the absence of an established definition of the construct has been resolved.  CPTSD 
has formally been introduced into the diagnostic nomenclature in the eleventh edition of the 
International Classification of Diseases and Related Health Problems (ICD-11), the 
diagnostic system of the World Health Organization (WHO). Given that CPTSD is a new 
disorder, there are as yet no treatment studies assessing interventions that would be effective 
for the disorder, nor which of possible available treatment interventions will prove to be 
optimal. The purpose of this paper is to present the rationale for offering a patient-centred 
approach to the treatment of and research about CPTSD, it’s feasibility and potential benefits. 
The paper concludes with a broad description of research methods and implementation 
science practices to guide future research in the treatment of CPTSD.    
CPTSD: Patient Characteristics and Central Symptoms 
The diagnosis of CPTSD is organized into two over-arching groups of symptoms, 
those related to traumatic stimuli (PTSD) and those related to disturbances in self-
organization (DSO). The three clusters of PTSD symptoms have been derived from decades 
of research (i.e., re-experiencing, avoidance and sense of threat (see Brewin et al., 2017). The 
DSO symptoms are organized into three categories that describe three conceptually distinct 
problem domains: namely problems with affect regulation, problems with self-identify and 
problems in relating to others. The two-factor formulation of CPTSD appears to be easy for 
clinicians to correctly identify as demonstrated by high rates of accurate differential diagnosis 
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between CPTSD and PTSD and as compared to normality among over 1700 clinicians in 73 
countries (Keeley et al., 2016).  
An important step in identifying interventions that are particularly or more precisely 
relevant to the treatment of CPTSD is to explore patient characteristics that are associated 
with CPTSD as compared to PTSD and to understand the relationship of symptoms and 
symptom clusters to one another.  In regard to patient characteristics, Karatzias and 
colleagues (2018) assessed the predictive strength of emotion regulation strategies, negative 
trauma-related cognitions and attachment style on the diagnosis of ICD-11 CPTSD as 
compared to PTSD. All three patient characteristics were differential predictors of CPTSD 
versus PTSD.  The most significant differential predictor of diagnosis was negative 
cognitions about the self, characterised by a generalised negative view about the self and 
one’s trauma symptoms; this was followed by attachment anxiety, which was defined as 
involving a fear of interpersonal rejection or abandonment and / or distress if one’s partner is 
unresponsive or unavailable; the third differential predictor was expressive suppression, 
characterized by efforts to hide, inhibit, or reduce emotional expression.  
These results indicate that negative self-concept is a highly salient characteristic of 
CPTSD. Indeed, using a very different analytic approach, two network analyses of CPTSD 
symptoms in community clinical samples (Kneffel et al., 2018) and population-based trauma 
samples (Kneffel et al., 2019) found similar results indicating that negative self-concept was 
the most central aspect of the CPTSD formulation. Network analysis allows for visual 
representation of symptoms and can identify which symptoms are central regarding strength 
and number of interactions with other symptoms. In theory, identification of these symptoms 
mark the most significant symptoms of the disorder and potentially an important treatment 
target. In the analysis of CPTSD symptom data from four nationally representative samples 
(Germany, Israel, the UK, and the USA), negative self-concept, specifically “feelings of 
Treating Adults with CPTSD                                                                                                   5 
 
worthlessness” was central across all four sample regardless of differences in language, 
culture and types of traumas to which the populations had been exposed (Knefel et al., 2019).    
Given these data, Karatzias et al. (2018) concluded that negative self-concept, specific 
types of attachment-based fears and emotion dysregulation in the form of inhibited emotional 
expression were differentially associated with CPTSD compared to PTSD.  Interventions 
which address each of these problems in ways that are relevant to their particular content and 
dynamic may enhance treatment benefits. For example, it has been argued that severely 
negative views of self may be particularly responsive to compassion focused interventions 
(Gilbert & Irons, 2004). Furthermore, while emotion regulation difficulties are indirectly 
addressed in many treatments (e.g., via focused breathing training preceding exposure), direct 
psychoeducation on the impact of chronic trauma on emotion regulation and skills training in 
emotional expression might be helpful. Lastly, inclusion of psychoeducation regarding the 
impact of trauma on attachment and relational capacities may help “normalize” problems 
while interventions focused on increasing social engagement and relationship satisfaction and 
satisfaction in social engagement may be help resolve interpersonal difficulties.    
This section has identified problems that are particularly salient to those with CPTSD 
and provided suggestions for interventions that might be of benefit. However, this does not 
answer questions concerning how to introduce new interventions into existing treatments. If 
new interventions are to be integrated into existing treatments how might this work? The 
following sections address these questions by introducing the treatment frame of “patient 
centred care” as a guide for future research.     
The ICD-11 formulation of post-traumatic reactions into two rather than one disorder 
is consistent with a personalized medicine approach to treatment care. ICD-11 CPTSD has a 
greater number of different kinds of symptoms and typically results from more chronic and 
greater number of traumatic exposures. Studies comparing ICD-11 PTSD to ICD-11 CPTSD 
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have consistently found that CPTSD is associated with significantly poorer functioning, 
greater comorbidity and poorer quality of life compared to ICD-11 PTSD (e.g., Brewin et al., 
2017, Cloitre et al., 2019; Karatzias et al., 2017).  These data suggest that CPTSD is more 
severe than PTSD in clinically meaningful ways and that treatment of CPTSD may require a 
greater number of treatment interventions and/or a longer duration of treatment than PTSD. 
The difference between the two disorders in terms of their complexity and severity is 
expected to translate into treatment plans that personalize interventions specific to each 
disorder that will help optimize outcome for the individual patient while efficiently deploying 
limited mental health resources.  
The development of different treatments is motivated by the presence of different 
disorders with different symptoms and associated levels of impairment. However, it is 
possible that patient populations with two different disorders could use the same treatments 
and have equally good outcomes. The next section of this paper reports on the results of two 
meta-analyses investigating this question.    
Limitations in Current Evidence Based Treatments    
The vast majority of evidence to date for the treatment of psychological trauma has 
been based on DSM-IV PTSD, which is a condition of three clusters of symptoms, 
resembling to high degree the new ICD-11 PTSD. Existing treatment guidelines for PTSD 
propose psychotherapeutic approaches as the first line of support for psychological trauma, 
and recommend trauma-focused psychological therapies, such as cognitive-behavioral 
therapy (CBT), and Eye Movement Desensitization and Reprocessing (EMDR) for 
Posttraumatic Stress Disorder (PTSD) (e.g., National Institute for Clinical Excellence 
[NICE], 2005; Australian Centre for Posttraumatic Mental Health [ACPMH], 2007). Trauma-
focused treatments typically include repeated in vivo and/or imaginal exposure to the trauma, 
reappraisal of the meaning of the trauma and its consequences, or some combination of these 
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techniques. These therapies have been identified as efficacious for a range of PTSD 
survivors, including rape victims, survivors of childhood abuse, refugees, combat veterans, 
and victims of motor vehicle accidents (Foa, Keane, Friedman, & Cohen, 2009). 
Nevertheless, two recent meta-analyses have suggested that certain subgroups of patients may 
experience less benefit than others, and in addition, the effectiveness of the treatments may 
vary by type of outcome.    
In the meta-analysis completed by Karatzias and colleagues (2019), randomized 
controlled studies of PTSD were reviewed which included not only measures of the three 
symptom clusters of PTSD but also those specific to CPTSD, namely affect dysregulation, 
negative self-concept, and disturbances in relationships. Analyses assessing outcomes for 
each of the six specific symptom clusters, as they were available across studies, revealed that 
as compared to waitlist or treatment as usual, cognitive-behavioral therapies, exposure alone 
and EMDR yielded superior outcomes. However, this effect was negatively moderated by 
childhood abuse, where outcomes for each of the six symptom clusters were consistently less 
positive for the subgroup of participants with childhood trauma.  
A second meta-analysis following a similar strategy to estimate the benefits of current 
therapies for CPTSD was conducted by Coventry and colleagues (2019). The investigators 
found that both trauma and non-trauma focused therapies provided substantial benefits for 
PTSD symptoms but noted that the positive effects for the DSO symptom clusters (i.e., affect 
dysregulation, negative self-concept and interpersonal problems), were modest. There was 
some suggestion that multi-component therapies provided better outcome, particularly among 
childhood sexual abuse survivors.   
Overall, these two meta-analyses suggest that while current therapies are effective, 
they proved lesser benefits for those likely to have CPTSD and that multicomponent 
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therapies might be one approach by which to improve outcomes.  The evidence indicates that 
current therapies may serve as the basis for or be one component of CPTSD treatment. 
Identifying which treatment interventions or components might be integrated into existing 
therapies requires better understanding of the disorder and of characteristics of the individuals 
who have the disorder.   
Patient Centred Care for CPTSD 
The core principle of patient-centred care is recognition that symptoms or problems 
that are important to one individual with a particular condition are not necessarily important 
for another individual with the same condition. Patient-centred care also acknowledges that 
the needs of the individual change over time as s/he receives care from services (Health 
Foundation, 2014). The meta-analytic analysis described above (Coventry, 2018) revealed 
that patients likely to have CPTSD have higher attrition rates than other patients. One means 
by which to reduce attrition is to create treatment programs that are tailored to the specific 
concerns for which the patient seeks treatment. Similarly, ongoing assessment of symptoms 
or patients’ concerns provide the basis for reasoned shifts in treatment focus and 
interventions, potentially strengthening patient engagement and leading to increased benefits.  
 The Health Foundation (2014) has identified a framework that comprises four 
principles of person-centred care including affording people dignity, compassion and respect, 
offering coordinated care, support or treatment, offering personalised care, support or 
treatment and lastly, supporting people to recognise and develop their own strengths and 
abilities to enable them to live an independent and fulfilling life. In this framework, the role 
of the health care professional is to enable the individual to make decisions about their own 
care and treatment on the basis of their needs. A number of health and economic outcomes 
have been associated with person centred care including less use of emergency services (De 
Silva, 2011), greater treatment adherence (De Silva, 2012a) and greater patient satisfaction 
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(Rathert et al., 2012). Patient centred care has also been associated with increased staff 
performance and morale (De Silva, 2012b).  
Patient-centered care is central to the policies of the UK and the United States. For 
example, the Health and Social Care Act 2012 imposes a legal duty for NHS England and 
clinical commissioning groups (CCGs) to involve patients in their care (The Kings Fund, 
2012).  Similarly, in the United States, the recent mandate for patient-centred care, associated 
with the Patient Protection and Affordable Care Act of 2010, has articulated that patient-
centred care requires the identification of outcomes about which patients care, the 
development of treatments that address these concerns, and research which routinely includes 
patient preference as a relevant factor in the selection of the optimal treatment.  
This theoretical frame and commitment to patient-centred care supports the selection 
of a treatment approach for future research, namely the evaluation of flexible modular and 
sequential treatment programs where treatment goals and interventions are ordered according 
to patient recovery stage, needs and preferences.  
Modular Treatments  
The presence of CPTSD diagnosis is expected to enhance treatment outcomes by 
facilitating the development of treatment plans that tailor the selection of interventions and 
their delivery more closely to the needs of a patient with CPTSD versus patients with PTSD. 
However, as suggested above, the “lessons learnt” about personalizing care extend beyond 
matching a manualized treatment program to a specific trauma disorder.  The movement from 
manualized treatment to personalized care suggests treatment planning attends to the 
individual per se not just an individual with CPTSD rather than PTSD. While the general 
notion of personalized care is not new to mental health practice (see British Psychological 
Society, 2011), there has been little to no research in this approach in the trauma field.   
 We propose a flexible modular approach to the treatment of CPTSD where patient 
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and therapist collaborate on the selection of a set empirically supported treatment modules 
or interventions intended to resolve specific problems of concern. This treatment strategy is 
viable for several reasons. First, CPTSD has two relatively distinct symptoms clusters 
(PTSD and DSO) allowing therapists and clients to assess which problems are of greater 
concern and selecting interventions accordingly. Second, there is precedent for the 
successful use of a flexible modular treatment approach in mental health albeit with 
paediatric populations. Third, there is indirect evidence of the success of multi-modular 
treatments in trauma populations. Relevant research is presented as follows. 
 The use of a flexibly-applied multi-modular treatment approach is new to the trauma 
field signalling a treatment innovation and paradigm shift in clinical approach research 
methodology. However, there is a good rationale for its application and a successful 
precedent in mental health that lays out a methodological road map for its testing. First, 
such approaches have been found to be more effective compared to use of full protocols for 
a single disorder (Daleiden, Chorpita, Donkervoet, Arensdorf, & Brogran, 2006) or to the 
sequencing of full protocols for different disorders (Weisz et al., 2012). Second, the 
treatments appear to have a second benefit for patients in that they tend to be shorter and so 
time and expense burdens on the patient (Weisz et al., 2012).  Third and relevant to 
treatment uptake of evidence-based therapies (EBTs), clinicians trained in a modular 
therapy versus those trained in disorder-specific manualized therapy showed improved 
attitudes about evidence-based practices (Borntrager, Chorpita, Higa-McMillan, & Weisz, 
2009). Moreover, clinicians reported greater satisfaction with modular treatments as 
compared to standard evidence-based and reported assessed them as more effective as 
compared to usual care, suggesting that modular treatments provide the “best of both 
worlds” with high ratings on both practitioner satisfaction and effectiveness (Chorpita et al., 
2015).   
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Several trauma-focused therapies have used forms of modular or sequenced 
approaches. They differ from the current proposal in that modules were used in a specific 
sequence while the current proposal suggest that the selection of modules be flexibly ordered 
and applied based on patient symptoms and preferences. The benefits of these approaches, 
however, demonstrate their feasibility and potential success among trauma patients. Some of 
these therapies include STAIR Narrative Therapy (formerly STAIR plus modified exposure), 
Eye Movement Desensitization and Reprocessing (EMDR) and Brief Eclectic Psychotherapy 
(BEPP) to treat PTSD (see Schnyder & Cloitre, 2015 for description of these treatments). In 
addition, there has been formulation of modular or sequenced treatments for addressing 
comorbid BPD and PTSD developed by Harned and colleagues (Harned et al., 2014) in 
which dialectical behaviour therapy is initiated to resolve suicidal and self-injurious 
behaviour and once controlled, is followed by prolonged exposure (PE) (see Schnyder & 
Cloitre, 2015).  
At least one randomized controlled study has applied a modular approach to a 
complex trauma population (childhood abuse survivors) and provided specific attention to 
emotion regulation and interpersonal difficulties (Cloitre et al, 2010).  In this study the test 
condition sequenced a module focused on improving emotion regulation and interpersonal 
problems (Skills Training in Affective and Interpersonal Regulation (STAIR) followed by a 
module which added a  trauma memory processing intervention (Narrative Therapy). The 
study compared the sequenced treatment with two other conditions where in each condition 
one or the other module was removed and replaced with a generic active nonspecific 
supportive counselling. Results indicated that overall, the combination treatment, STAIR 
Narrative Therapy, provided greater improvement in PTSD symptoms, emotion regulation 
and interpersonal problems than the two comparator conditions. The attrition rate in the 
combination treatment was lower than that in narrative-focussed condition while that for the 
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skills-focused condition fell in the middle. The reasons for this differential attrition rate 
cannot be identified but may relate to the presence of multiple interventions that were of 
interest and relevant to patients, supporting patient engagement throughout the treatment.   
The above findings suggest the potential benefits of modular sequenced treatments in 
terms of  attrition rates and outcomes relevant to CPTSD symptom clusters. Further research 
is needed to determine whether additional or different modules might be of equal or greater 
value. The treatment did not address (nor measure) issues related to negative self-concept, 
which has been identified as a central symptom of CPTSD.. To our knowledge, no studies 
engaging trauma populations have tested the differences regarding the order of modules or 
the benefits of including flexibility in the order of the modules based on patient symptoms 
and preferences. It might be suggested that most patients would prefer to start with skills 
training as a strategy to avoid discussing their trauma history. This is a hypothesis that 
remains to be tested. Patients may be willing and desirous of discussing their trauma, once 
given the freedom to choose and evaluate the potential pros and cons of different types of 
sequencing strategies.  
Existing therapies and treatment modules 
The above literature suggests the feasibility of multi-modular treatment approaches as 
well as some evidence suggesting its potential benefits for trauma populations. There are 
several types of interventions or modules that might be developed and considered as relevant 
to the CPTSD population. These include for example emotion regulation intervention 
modules (e.g., focused breathing, emotional awareness and self-soothing exercises),  
interventions to address negative self-concept (e.g., cognitive re-appraisal of self-worth, self-
compassion) and modules to address interpersonal difficulties (e.g., communication skills, 
cognitive flexibility around interpersonal expectations, interventions addressing problems 
with anger and intimacy) and potentially developmentally informed strategies to reset 
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attachment representations (Liotti, 2004).  The PTSD symptom clusters which are an equally 
important part of the CPTSD can be addressed via exploring and making meaning of the 
trauma (exposure, narratives, cognitive processing). 
  In the most flexible version of the multi-modular approach, there is no fixed ordering 
of sequences at the outset of treatment. Rather, the selection of the module or intervention is 
adjusted according to the patient’s treatment response over time (Lei, Nahum-Shani, Lynch, 
Oslin, & Murphy, 2012). Assessment of CPTSD symptoms would be routinely made through 
the course of therapy, as more than one problem may resolve with the use of a single module 
or intervention. Selection of the sequence of modules or interventions would be based on 
updated symptom reports evaluated in a collaborative fashion between therapist and patient. 
Limitations of a flexible multi-modular approach must also be considered.  First, there 
may be several interventions and modules appropriate for the CPTSD patient population, 
which may in turn create a burden on therapists to be informed about and skilled in the use of 
several different techniques. This might be resolved through the use of technology where 
apps or web-based programs provide guidance to both the provider and patient. Second, there 
may be greater reliance on the clinician’s skill in building a therapeutic alliance with the 
patient and resolving conflicts when differences emerged between therapist and patient 
regarding which interventions to use and their order. The resolution of this problem would 
require discussion very early in the treatment to identify treatment goals, symptom targets 
and interventions likely to be used in the program. Third, the use of adaptive treatment 
requires routine assessment of symptoms for feedback and decision making, a dimension of 
treatment process which is not routine and which may be viewed as burdensome. The use of 
brief assessments and an explanation of their key role in the treatment may help resolve 
resistance to this task.  Finally, the application of modular therapy will require therapists 
making judgments of what treatments to choose, when to choose, how to communicate and 
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make the decision with the clients, and how to assess the outcome of different sequences as 
well as selection of modules. Appropriate support at service level including the use of clinical 
supervision can be particularly useful in supporting clinicians to make these choices. 
  
Directions for Future Research in the Treatment of CPTSD 
CPTSD is a debilitating condition associated with severe functional impairment. 
There is now an urgent need for research in the area of CPTSD treatment. This paper has 
identified a promising treatment approach namely flexible modular approach and provided 
the rationale and the emerging evidence for it. However, there are several directions for 
future research that can be considered and deserve mention. The simplest RCT may involve 
comparing the differential effectiveness of established treatment between patients with ICD-
11 CPTSD compared to  PTSD and assess the relative benefits of as-needed increases in the 
treatment dose  (e.g., increased number of sessions or addition of booster sessions following 
treatment). A second design would include the addition of interventions or modules to an 
existing PTSD treatment where additions explicitly target DSO symptoms. In this design, 
treatment conditions could test the potential benefit of the additional component compared to 
the standard treatment (e.g. STAIR+CPT (or PE) vs CPT (or PE) alone) or ordering effects 
(e.g. STAIR+CPT (or PE), CPT (or PE)+STAIR vs. CPT (or PE) alone). The use of 
established treatments as benchmark comparator is important as it remains unknown whether 
sequential or integrated treatments are superior to already established treatments for CPTSD.  
The feasibility and efficacy of novel treatments compared to waitlist are also to be 
considered. These might include the adaptation of treatments for other disorders or from other 
traditions as has been conducted with Interpersonal Psychotherapy (IPT) and mindfulness 
therapy.   
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More complex designs might include comparison of different kinds sequencing 
strategies where, for example, in one condition patient choice drives the sequencing of 
treatment in comparison to a condition with a fixed sequence and where both conditions are 
compared to an existing treatment. Lastly, the most complex design would involve a 
condition in which treatment sequences are open-ended at the beginning of treatment and the 
selection of each new module is determined by the patient’s response after each module, an 
approach which is call “sequential, multiple assignment randomized trials” or SMART (see 
Lei et al, 2012). However, it should also be acknowledged that such designs require large 
samples and this can only be achieved through multi-centred studies. 
In all these designs, symptom assessment occurs at regular intervals throughout the 
course of treatment to determine whether, when, and how much symptom change is 
occurring. The relative speed of change for PTSD as compared to DSO symptoms is 
unknown as is the way in which these symptoms may influence one another over time. 
Adaptive designs such as SMART require periodic assessment of treatment outcomes and 
processes so that clinicians and patients can receive feedback about patient progress and 
make informed treatment decisions, otherwise known as “measurement feedback systems.”   
These assessments need to be psychometrically sound, sensitive to clinical change and brief 
enough for frequent administration (Ng & Weisz, 2016). To date, there is at least one brief, 
validated measure of CPTSD which includes symptom assessment of all six symptom 
clusters (Cloitre et al., 2018).  
Lastly, the evaluation of the effectiveness of treatments for CPTSD might best be 
considered in the context of real-world clinics, implemented by community clinicians, 
provided to clinic patients with fewer inclusion and exclusion criteria. The use of pragmatic 
trials can facilitate the transition from evaluation to implementation and dissemination of a 
treatment if it is found effective. Moreover, research indicates that even when a treatment is 
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identified as effective, clinician uptake can be limited if the treatment delivery is rigid and 
does not appear to be adaptable to the needs of individual patients (Nelson, Steele, & Mize, 
2006). Collection of qualitative data (e.g., interview data) from clinicians about perceptions 
regarding the flexibility or adaptability of the program will help identify and resolve trouble 
spots in a treatment protocol and facilitate dissemination of the protocol if successful.  
The advent of the CPTSD diagnosis has arrived at a time of a paradigm shift in 
clinical trials methodology. Research is moving away from traditional RCTs, which have 
provided useful information about the average outcomes of a treatment, to a personalized 
medicine approach that evaluates the potential benefits of tailoring treatments goals, 
interventions and outcomes specific to the individual patient. Given that highly traumatized 
patients have experience substantial loss of autonomy, mastery, and perceived support, a 
treatment paradigm in which the patient directs the treatment content and goals supported by 
a knowledgeable provider would likely be empowering for patients ultimately leading to 
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